Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

FDC Ltd

NSE: FDC · BSE: 531599 · Pharmaceuticals & Biotechnology · 28 announcements

Share price
₹329.60
Market cap
₹5,366 Cr
Revenue (annual)
₹2,171 Cr
Net profit (annual)
₹281.4 Cr
P/E (TTM)
18.3×Sector 47.4×
Promoter holding
69.66%+0.00% QoQ
FII holding
1.40%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

14:23 IST BSE
Regulatory Approval

FDC Regulatory Approval

FDC Limited's subsidiary, FDC International Limited, received marketing authorization from MHRA, UK for Atropine 1.0% eye drops. This regulatory approval enables product commercialization in the United Kingdom.

10:45 IST NSE
Regulatory Approval

FDC Regulatory Approval

FDC Limited received U.S.FDA ANDA approval for Cefixime Oral Suspension USP in two strengths. This regulatory milestone enables the company to market these products in the US.